FR13C0008I2 - Derives de phosphonocephem, leur procede de preparation et leur utilisation - Google Patents

Derives de phosphonocephem, leur procede de preparation et leur utilisation

Info

Publication number
FR13C0008I2
FR13C0008I2 FR13C0008C FR13C0008C FR13C0008I2 FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2 FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2
Authority
FR
France
Prior art keywords
preparation process
phosphonocephem
derivatives
phosphonocephem derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR13C0008C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Lim
Original Assignee
Takeda Pharmaceutical Co Lim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18417716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR13C0008(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Co Lim filed Critical Takeda Pharmaceutical Co Lim
Publication of FR13C0008I1 publication Critical patent/FR13C0008I1/fr
Application granted granted Critical
Publication of FR13C0008I2 publication Critical patent/FR13C0008I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FR13C0008C 1997-12-19 2013-02-06 Derives de phosphonocephem, leur procede de preparation et leur utilisation Active FR13C0008I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35149997 1997-12-19
PCT/JP1998/005709 WO1999032497A1 (fr) 1997-12-19 1998-12-17 Derives de phosphonocephem, leur procede de preparation et leur utilisation

Publications (2)

Publication Number Publication Date
FR13C0008I1 FR13C0008I1 (cs) 2013-03-22
FR13C0008I2 true FR13C0008I2 (fr) 2013-08-16

Family

ID=18417716

Family Applications (1)

Application Number Title Priority Date Filing Date
FR13C0008C Active FR13C0008I2 (fr) 1997-12-19 2013-02-06 Derives de phosphonocephem, leur procede de preparation et leur utilisation

Country Status (19)

Country Link
US (1) US6417175B1 (cs)
EP (2) EP2080765A1 (cs)
JP (3) JP3467418B2 (cs)
KR (1) KR100384047B1 (cs)
CN (2) CN1194980C (cs)
AT (1) ATE430155T1 (cs)
AU (1) AU1683299A (cs)
BE (1) BE2013C004I2 (cs)
CA (1) CA2314564C (cs)
CY (2) CY1109276T1 (cs)
DE (1) DE69840796D1 (cs)
DK (1) DK1043327T3 (cs)
ES (1) ES2325139T3 (cs)
FR (1) FR13C0008I2 (cs)
LU (1) LU92134I2 (cs)
NL (1) NL300568I2 (cs)
PT (1) PT1043327E (cs)
TW (1) TW473479B (cs)
WO (1) WO1999032497A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100826487B1 (ko) * 2000-08-10 2008-05-02 다케다 야쿠힌 고교 가부시키가이샤 포스포노세펨 화합물
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN101357929B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有巯基噻二唑的头孢菌素衍生物
CN101868240A (zh) * 2007-09-21 2010-10-20 阿斯利康(瑞典)有限公司 适合肠胃外给药的包含头孢烯衍生物的可溶剂型
CN103212076A (zh) * 2008-08-28 2013-07-24 阿斯利康(瑞典)有限公司 包含头孢洛林的组合物和治疗方法
US8247400B2 (en) * 2009-02-23 2012-08-21 Dedhiya Mahendra G Cephem compounds useful for the treatment of bacterial infections
BR112012006250B1 (pt) * 2009-09-21 2021-07-06 Pfizer Anti-Infectives Ab composições para tratar infecções bacterianas usando ceftaroline
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
EP2721005B1 (en) 2011-06-17 2015-11-25 AstraZeneca AB Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
EP2788361A1 (en) 2011-12-07 2014-10-15 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
JP6301346B2 (ja) * 2012-10-19 2018-03-28 サンド・アクチエンゲゼルシヤフト セフタロリンフォサミルの新規製造方法
CN102977124B (zh) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法
US9534004B2 (en) 2012-12-20 2017-01-03 Sandoz Ag Crystalline forms of ceftaroline fosamil
CN105612166B (zh) 2014-02-21 2019-02-19 上海盟科药业有限公司 治疗用水溶性(o-羰基)氨基磷酸酯前药
CN106565784B (zh) * 2016-10-31 2019-02-26 瑞阳制药有限公司 头孢洛林酯二钠盐的纯化方法
CN110872322B (zh) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 乙酸头孢罗膦一水合物及其中间体的制备方法
CN113072567B (zh) * 2021-03-26 2022-10-14 海南海灵化学制药有限公司 一种拉氧头孢钠合成工艺
CN113214323A (zh) * 2021-04-30 2021-08-06 瑞阳制药股份有限公司 分段式头孢罗膦高效稳定析晶方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (ja) 1975-07-24 1984-10-11 武田薬品工業株式会社 セフエムまたはベナム化合物の製造法
US4268509A (en) 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
JPS5511600A (en) 1978-07-10 1980-01-26 Fujisawa Pharmaceut Co Ltd Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same
FR2511372A1 (fr) 1981-08-17 1983-02-18 Rhone Poulenc Sante Nouveaux derives de la cephalosporine et leur preparation
JPS5931791A (ja) 1982-07-19 1984-02-20 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤
US4563449A (en) 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS62238291A (ja) * 1986-04-10 1987-10-19 Fujisawa Pharmaceut Co Ltd セフエム化合物および医薬として許容されるその塩
US4978663A (en) 1989-08-16 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
JP3514495B2 (ja) 1992-10-02 2004-03-31 エーザイ株式会社 ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法
JP3927262B2 (ja) 1995-07-19 2007-06-06 武田薬品工業株式会社 セフェム化合物、その製造法および抗菌組成物
JPH10265488A (ja) * 1997-03-27 1998-10-06 Takeda Chem Ind Ltd ホスフォノセフェム誘導体

Also Published As

Publication number Publication date
EP1043327B1 (en) 2009-04-29
CY2013003I2 (el) 2015-08-05
EP1043327A4 (en) 2001-12-12
EP2080765A1 (en) 2009-07-22
PT1043327E (pt) 2009-07-02
JP2009114202A (ja) 2009-05-28
NL300568I1 (cs) 2016-01-18
DK1043327T3 (da) 2009-08-17
FR13C0008I1 (cs) 2013-03-22
ATE430155T1 (de) 2009-05-15
KR20010015885A (ko) 2001-02-26
CY2013003I1 (el) 2014-07-02
AU1683299A (en) 1999-07-12
CA2314564A1 (en) 1999-07-01
JP3467418B2 (ja) 2003-11-17
CN1282335A (zh) 2001-01-31
WO1999032497A1 (fr) 1999-07-01
ES2325139T3 (es) 2009-08-26
US6417175B1 (en) 2002-07-09
EP1043327A1 (en) 2000-10-11
CY1109276T1 (el) 2014-07-02
TW473479B (en) 2002-01-21
BE2013C004I2 (en) 2018-01-29
CN1679595B (zh) 2010-05-12
JP2001048893A (ja) 2001-02-20
NL300568I2 (cs) 2016-01-18
CA2314564C (en) 2008-11-18
LU92134I2 (fr) 2013-03-18
CN1679595A (zh) 2005-10-12
KR100384047B1 (ko) 2003-05-14
DE69840796D1 (de) 2009-06-10
CN1194980C (zh) 2005-03-30
JPH11255772A (ja) 1999-09-21

Similar Documents

Publication Publication Date Title
FR13C0008I2 (fr) Derives de phosphonocephem, leur procede de preparation et leur utilisation
FR2784107B1 (fr) Microfibrilles de cellulose a surface modifiee, leur procede de preparation, et leur utilisation
EP0710667A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
FR2732680B1 (fr) Composes de type ceramides, leur procede de preparation et leur utilisation
FR2660556B1 (fr) Microspheres, leur procede de preparation et leur utilisation.
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
NO975977L (no) Substituerte purinderivater, fremgangsmÕter for fremstilling og anvendelse derav
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
NO960499L (no) Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner
FR2680506B1 (fr) Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
EP0978524A4 (en) FLUOROPOLYMERS, METHOD FOR THEIR PRODUCTION AND THEIR USE
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
FI954946A7 (fi) Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
PT931087E (pt) Novos derivados de piranosido
FR2755439B1 (fr) Derives aryloxypropanolamines, leur procede de preparation et leurs applications
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
MA26590A1 (fr) Derives de thiazole, leur procede de preparation et leur utilisation.
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
FR2725450B1 (fr) Aminoplastes, procede pour leur preparation et leur utilisation
FR2769627B1 (fr) Derives de (3-oxoisoindoline-1-ylidine) propanedinitrile et leur procede de preparation